Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000737

Director sold 41,312 shares at an average $17.63 ($728,134)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-07-27 Sale : show line 1 in the form −40,912 $17.63 $721,074 2,282,734 I
2017-07-28 Sale : show line 2 in the form −400 $17.65 $7,060 2,282,334 I
Open-market sales · 41,312 sh · avg $17.63 · $728,134
Loading xslF345X03/vonemster_fm4july272017.xml…